PI at the University of Zürich. Natural Products Discovery, Metabolomics, Bacteria Metabolites, Cyanobacteria Blooms, Quorum Sensing, Chemoselective Probes, Diazeniumdiolates. https://www.simonsiebergroup.com/
Simon Sieber
We built GenoPHI: a machine learning workflow that predicts phage-host interactions at strain level. This could help rapidly select phages to treat drug-resistant bacterial infections or for microbiome engineering without exhaustive lab testing.
www.biorxiv.org/content/10.1...
www.biorxiv.org
Avery Noonan
Our highlight review on recently isolated cyanobacterial metabolites is out @natprodreports.rsc.org !🥳 Covers isolation, structure elucidation (analytical techniques, biosynthesis and total synthesis). Great work with @elisabethjanssen.bsky.social!
@chem.uzh.ch
pubs.rsc.org/en/content/a...
Covering: 2021 to 2024This review highlights cyanobacteria secondary metabolites reported between 2021 and 2024. Those compounds are categorised into major classes, including peptides, alkaloids, lipi...
Thanks to the organisers for a fantastic #ICTC13 and to all the participants for the super fruitful discussions. It was my first ICTC and I had such a wonderful experience 🤩. I'm so looking forward to ICTC14 👀
@ictc13.bsky.social
🔓Take a look at this #OpenAccess review from @simonsieber.bsky.social & @elisabethjanssen.bsky.social in our latest issue highlighting the cyanobacterial metabolites reported between 2021–2024 #natprod #secmet
📍 @chem.uzh.ch, @eawag.bsky.social
